Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Characterization of meningeal inflammation in progressive multiple sclerosis and correlation to clinical and pathological severity

EF 2019-20

Résumé
"Multiple sclerosis (MS) is a disease of the brain and spinal cord in which the protective covering of the nerves is destroyed due to inflammation. While treatment options exist for the less severe, relapsing form of MS, there has been limited success in modulating the progressive, more severe form of MS. Our failure to effectively treat progressive MS is due to the fact that the molecular signals that drive MS progression remain unclear. Further, although immune cells continue to cause pathology, they reside behind a brain barrier that is largely intact and prevents the entry of drugs. I propose that the meninges - the membranous, cerebrospinal fluid (CSF) filled lining of the brain - contain a unique composition of immune cells that cause irreversibly injury to the brain during progressive MS. I propose these cells trapped in the meninges secrete molecules that are able to enter the brain and cause pathology. I also expect these secreted molecules to be present in the CSF. To investigate this hypothesis, I will use brains from MS patients to fully characterize the MS meninges and the underlying brain area. By comparing brains from MS patients to brains from non-MS patients with meningeal inflammation (for ex., encephalitis), I hope to pinpoint unique characteristics that are specific to the MS meninges. I will also compare the cerebral spinal fluid between the same MS patients and non-MS patients with meningeal inflammation to identify secreted molecules that differ between the two groups. This project will enhance our understanding of progressive MS and allow us to identify secreted molecules that correlate to clinical and pathological severity. Ultimately, future blockade of the molecules identified by this project could alter MS disease course."
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
428808
Name
Florescu Alexandra
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterization of meningeal inflammation in progressive multiple sclerosis and correlation to clinical and pathological severity
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Multiple Sclerosis; Neuroimmunology
Abstract
"Multiple sclerosis (MS) is a disease of the brain and spinal cord in which the protective covering of the nerves is destroyed due to inflammation. While treatment options exist for the less severe, relapsing form of MS, there has been limited success in modulating the progressive, more severe form of MS. Our failure to effectively treat progressive MS is due to the fact that the molecular signals that drive MS progression remain unclear. Further, although immune cells continue to cause pathology, they reside behind a brain barrier that is largely intact and prevents the entry of drugs. I propose that the meninges - the membranous, cerebrospinal fluid (CSF) filled lining of the brain - contain a unique composition of immune cells that cause irreversibly injury to the brain during progressive MS. I propose these cells trapped in the meninges secrete molecules that are able to enter the brain and cause pathology. I also expect these secreted molecules to be present in the CSF. To investigate this hypothesis, I will use brains from MS patients to fully characterize the MS meninges and the underlying brain area. By comparing brains from MS patients to brains from non-MS patients with meningeal inflammation (for ex., encephalitis), I hope to pinpoint unique characteristics that are specific to the MS meninges. I will also compare the cerebral spinal fluid between the same MS patients and non-MS patients with meningeal inflammation to identify secreted molecules that differ between the two groups. This project will enhance our understanding of progressive MS and allow us to identify secreted molecules that correlate to clinical and pathological severity. Ultimately, future blockade of the molecules identified by this project could alter MS disease course."
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Florescu, Alexandra
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~